India CDSCO Updates
The latest guidances, approvals, and safety alerts from India CDSCO, curated by automated regulatory intelligence.
Amends Rule 43A of the Drugs Rules, 1945 to expand the list of approved inland container depots (ICDs), ports, and SEZs that may be used for the import of…
Establishes a proposal to amend the Drugs Rules, 1945 to require an authorized person responsible for batch release of drug products.
Rationalizes how shelf life is set under Rule 31 of the Drugs Rules, 1945, potentially requiring applicants to align stability evidence and shelf-life…
Appointment of a Central Compounding Authority suggests India may establish or formalize centralized oversight for compounding activities, potentially…
Highlights enforcement attention on the FatX solution’s registration under COS-2 (RC/COS-003300) due to misleading or false product claims, which may trigger…
Implements a digital monitoring approach via the ONDLS portal to track the supply chain of high-risk solvents, strengthening oversight and traceability of…
Reinforces the expectation that India-regulated drug manufacturers strictly comply with the Drugs Rules, 1945 when conducting testing for both raw materials…
Raises regulatory concern regarding misleading or false claims associated with FatX solution, registered under COS-2 (RC No.
Notifies that WHO has issued an alert regarding falsified DEFITELIO (defibrotide) 80 mg/mL concentrate for solution for infusion, identified in India.
Cancels a specified list of Ethics Committees (ECs) recognized by the CLA, which may affect the acceptability of ethics review for clinical trial approvals and…
Clarifies that an Export NOC requirement (as interpreted/applied by CDSCO) for r-DNA products may not apply uniformly to products that are already approved…
Notifies the appointment of Government Analysts for veterinary vaccines at CCSNIAH, Baghpat, thereby formalizing the laboratory/analytical authority…
Notifies the appointment of Government Analysts for veterinary vaccines at CCSNIAH, Baghpat, thereby clarifying the authorized laboratory/official testing…
Draft guidance for stakeholders on India CDSCO regulatory expectations for manufacturers of in-vitro diagnostic (IVD) medical devices, intended to solicit…
Cosmetic Registration Certificate No. RC/COS-005067 dated 05.07.2024 has been surrendered, indicating the certificate holder is discontinuing regulatory…
Drafts changes to the conditions attached to India CDSCO retail and wholesale licensing specifically in relation to advertisements.
Indiscriminate use of NSAIDs and antibiotics is being highlighted as a safety concern linked to increased risk of Chronic Kidney Disease (CKD), implying the…
Maintains/announces an official list of registered BA-BE study centres and bio-analytical laboratories for conducting bioavailability/bioequivalence work under…
Alerts regulated entities and the public to avoid use of cosmetics products that are not authorized by CDSCO, signaling enhanced compliance and potential…
Mandates amendments to India’s Drugs Rules, 1945 to require the mandatory installation of CCTV surveillance systems at drug sales premises.